Group 1, rabbits fed a standard diet
Dose adjustments should occur only under provider guidance
Some patients may qualify if they have: -A BMI of 35 or higher -A BMI of 30+ with conditions such as chronic kidney disease, uncontrolled high blood pressure, or heart failure -A BMI of 27+ with prediabetes, a previous heart attack, previous stroke, or symptomatic peripheral artery disease You will not be eligible if you are already receiving a GLP-1 medication through your Medicare coverage for a preexisting condition such as: -Type 2 diabetes -Moderate-to-severe sleep apnea -Certain liver conditions, including MASH Call Montgomery Medical today at 724-569-8100 or go online to schedule a consultation and see if you may qualify for the Medicare GLP-1 Bridge Program
Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease
PlexusDx Weight Management Protocols: the Microdose GLP-1 Protocol at $129/mo flat is among the cheapest published cash-pay GLP-1 options anywhere online below Wegovy tablets, below Tuyo, below Breeze, below MEDVi's ongoing rate, and well below Zepbound vials with the optional Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) layered on top so dosing is anchored to your GLP1R, FTO, MC4R, and TCF7L2 variants instead of a population-average titration schedule
Cycle Guidelines Common Cagrilintide + Tirzepatide Cycle Approaches Approach Full staggered titration Duration 24-week ramp + open-ended maintenance Off Period No standardized off period Best For Primary weight-loss strategy with full pathway coverage Approach Tirz-first, cag add-on Duration Stabilize tirzepatide at 10-15 mg, then add cag for 12+ weeks Off Period Cag can be cycled on its own Best For Users already on tirzepatide who want more satiety Approach Sub-maximal combination Duration Lower doses of each (e.g
